Efficacy and Safety of KW21052 Compared to Lyrica in the Diabetic Patients With Neuropathic Pain

NCT01863810 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

394

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathy

Interventions

DRUG: KW21052
DRUG: Lyrica
DRUG: Lyrica (low dose)
DRUG: Placebo of KW21052
DRUG: Placebo of Lyrica

Sponsor

KunWha Pharmaceutical Co., Ltd.